TECOS: Evaluation of Cardiovascular Outcomes after Treatment with Sitagliptin (MK-0431) in Patients with Type 2 Diabetes & Inadequate Glycemic Control on Mono- or Dual Combination Oral Antihyperglycemic Therapy, Protocol 082-00